Adhera Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $2,352,000 over the previous period. Total operating expenses were $1,618,000.
Profit Margin
| 2013 | 2.11M | -1.57M | -74.28% |
|---|---|---|---|
| 2014 | 500K | -6.47M | -1295.4% |
| 2015 | 680K | 3.33M | 490.74% |
| 2016 | 0 | -837.14K | |
| 2017 | 0 | -6.21M | |
| 2018 | 76.18K | -16.75M | -21992.17% |
| 2019 | 252K | -12.64M | -5015.87% |
| 2020 | 0 | -5.54M | |
| 2021 | 0 | -7.78M | |
| 2022 | 0 | 2.35M |
ATRX Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 252K | 76.18K | 0 | 0 | 680K | 500K | 2.11M |
Cost of revenue | 0 | 0 | 0 | 409K | 458.70K | 450.90K | 49.18K | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | -157K | -382.52K | -450.90K | -49.18K | 680K | 500K | 2.11M |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 240.98K | 907.49K | 108.85K | 801K | 686K | 715K |
Selling and marketing | 0 | 17K | 839K | 5.26M | 3.63M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.61M | 674K | 2.03M | 10.04M | 10.23M | 6.09M | 757.73K | 4.66M | 4.02M | 2.48M |
Operating income | -1.61M | -674K | -2.03M | -11.31M | -15.79M | -6.09M | -757.73K | -3.98M | -3.52M | -365K |
Other income (expenses), net | -496K | -5.67M | -1.72M | -662K | -5.98M | -127.93K | -75.1K | 7.32M | -2.95M | -996K |
Income before tax | -2.11M | -6.35M | -3.76M | -11.97M | -16.75M | -6.21M | -836.34K | 3.33M | -6.47M | -1.61M |
Income tax expense | -4.46M | 1.43M | 1.77M | 662K | 5.17M | 800 | 800 | -7.32M | 1.95M | -39K |
Net income | 2.35M | -7.78M | -5.54M | -12.64M | -16.75M | -6.21M | -837.14K | 3.33M | -6.47M | -1.57M |
Earnings per share | ||||||||||
Basic EPS | 1.02 | -11.97 | -10.19 | -23.32 | -30.92 | -12.65 | -3.53 | 20 | -52.59 | -18.55 |
Diluted EPS | 1.02 | -11.97 | -10.19 | -23.32 | -30.92 | -12.65 | -3.53 | -28 | -52.59 | -18.55 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |